Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer - sprookjes - yvandenbroek - TriplyDB

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

http://www.wikidata.org/entity/Q24801511

about

Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53 Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302.Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells.Proteomics in pancreatic cancer research.Hypoxia-Responsive Polymersomes for Drug Delivery to Hypoxic Pancreatic Cancer Cells.Bioluminescence imaging of angiogenesis in a murine orthotopic pancreatic cancer model.Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin.The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer.Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer.PAUF promotes adhesiveness of pancreatic cancer cells by modulating focal adhesion kinase.Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth Molecular signatures of sanguinarine in human pancreatic cancer cells: A large scale label-free comparative proteomics approach.APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.Establishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2.Imaging biomarkers to monitor response to the hypoxia-activated prodrug TH-302 in the MiaPaCa2 flank xenograft model.Autophagy in pancreatic cancer pathogenesis and treatment Hypoxia and angiogenesis in pancreatic cancer.Association between ALDH1+/CD133+ stem-like cells and tumor angiogenesis in invasive ductal breast carcinoma Identification of novel hypoxia response genes in human glioma cell line a172.Inhibition of protein synthesis by imexon reduces HIF-1alpha expression in normoxic and hypoxic pancreatic cancer cells.A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.Monitoring the effects of anti-angiogenesis on the radiation sensitivity of pancreatic cancer xenografts using dynamic contrast-enhanced computed tomography.MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells.Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study.Alteration of pancreatic cancer cell functions by tumor-stromal cell interaction.Inflammation and pancreatic cancer: disease promoter and new therapeutic target.Increased expression of PHD3 represses the HIF-1 signaling pathway and contributes to poor neovascularization in pancreatic ductal adenocarcinoma.Investigation into the potential for hypoxic interior of neoplasms to enhance HSPA expression in glioma.Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer.Bufalin exerts antitumor effects by inducing cell cycle arrest and triggering apoptosis in pancreatic cancer cells.Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia Upregulation of transgelin is an independent factor predictive of poor prognosis in patients with advanced pancreatic cancer.Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness.Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment.The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines.Lentivirus-mediated overexpression of TGF-β inducible early gene 1 inhibits SW1990 pancreatic cancer cell growth.Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.

P2860

Q24608066-1685451D-C205-431B-B6BC-8D53BF7F65F4 Q28482913-A788F164-83D8-463A-A189-380DC92FE765 Q28484635-F45A0081-10FB-48D4-80B3-6E0BABAF4B66 Q30826843-51C60EFE-8FDB-4393-BC27-86B6901BAB19 Q33778101-F14A6BB6-D491-4F70-A279-8540DD1F3F3A Q33791981-A8D9F985-2507-4097-88E4-5F4764372E9E Q33887252-170F1874-2923-4D53-AB82-BB8DC8BFC76D Q34050525-3498A285-9C98-4722-8E48-5F80DFE3C00D Q34221784-E906D450-39D8-4025-B623-3CDD84690D8F Q34226670-5B862C7F-6B99-40E9-AFE9-815ECFE585F9 Q34556212-B71730A4-2C7B-41C1-B0F4-EFA4A523C8A3 Q35014211-39B123B5-80C1-4757-A2E0-D315A8270A49 Q35046706-35E04D49-BF4C-4A41-8830-4604AB4C6528 Q35206699-A75D3CF0-43D8-478F-8906-FE31EA179032 Q35832995-8F05F899-1300-4A87-8DC5-7D9BDC8993B7 Q35870045-C25EB236-D43C-4D3F-9157-D74B000CA093 Q35986433-8F76ABEF-306A-426F-96C9-1F1E2D684AFD Q36109993-9B23557D-1248-4E2B-9769-5BCC38B219ED Q36135812-B5C0A878-E1BA-48A3-A6D2-875D85630B38 Q36572752-FDF4E519-1C4E-4681-9320-F5C164858D99 Q36640196-E43D4F04-447D-49B2-8E10-2FB1CE45B1AE Q36978100-62584C7B-C8A4-4812-B0E8-31A19AADE96A Q37024427-60C4634E-39FC-4E2C-86DB-F85863FC1DD3 Q37216895-1C3C2717-8075-4E89-BA67-B9E3257A41AE Q37597172-8E0BF4B8-7105-464B-8DB5-A10F4E94044D Q37696126-E8C53826-288E-4807-86A6-DC78797F592F Q38059165-8017788B-3629-42AF-956A-990E132602A2 Q38160480-A156D28C-6C08-40AB-A004-74D905C0A59A Q38167608-25B65DAA-5F31-4A66-929A-7226B58F9D1B Q38925253-5792BC14-D4C1-4FE9-A643-4A4F100BCF0F Q38994484-CC209EB9-F9F2-48AA-9BA1-9FCA07328DF8 Q39044826-6B2E696E-B2B5-4616-B0FD-AB5030B06C23 Q39064254-56558E71-EEC4-4A1A-9AD5-1040DE783AE1 Q39068039-5300FE75-BEB6-4DE7-A1BC-3F247A1371F7 Q39208398-C8810524-4D0F-4F65-B5F7-269D44E25998 Q39379114-40BFFBBA-888D-4701-9BBD-407F311D571C Q39388967-984DF7B9-81E4-4A58-83F8-EC57D6D5B8C0 Q39428420-0C531F66-11A9-4A11-A54F-7463609A9599 Q39552151-C74C4D60-4F54-4AEB-84A1-2AA92D3D3200 Q39580020-9BDEF6AC-7A5B-460F-9389-1B9E8FF22465

P2860

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

http://www.wikidata.org/entity/Q24801511

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

@ast

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

@en

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

@nl

type

label

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

@ast

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

@en

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

@nl

prefLabel

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

@ast

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

@en

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

@nl

P1433

Q24801511-23D1DFE7-DE84-42EA-9153-1A59BE4FF2D7

P1476

Q24801511-F9657417-CA57-4E56-8EB8-078CE6131B90

P2093

Q24801511-52AD446E-F205-4222-90E4-8BEEA0738A8B

Q24801511-89C18EAD-32D7-477B-9943-724808DB1148

Q24801511-CC6A77AB-5D8C-4A7F-BC07-076419A997FB

Q24801511-FE6AC046-D298-49C4-BEA6-49E58FC788E3

P2860

Q24801511-049F03ED-EED1-429C-8263-EAB2830292BE

Q24801511-10F48EFD-F811-47B1-8418-3F0486A975FD

Q24801511-140B3C98-01EF-4708-8A3A-E5D818452A2F

Q24801511-14102ECA-B2A5-43B5-8F48-F07AF097D6E3

Q24801511-1AFB692A-47EE-4060-9A79-DE68CBBFEEF7

Q24801511-1EB4FDAC-2278-43DA-A4FE-A3930FC2A4A9

Q24801511-204971C8-6501-4F2A-A792-50EECF7AE86D

Q24801511-21304C6A-9B84-46D2-8F81-115B7E041BDA

Q24801511-2324A4AA-EA2A-4704-AF4F-9E1A550F1B89

Q24801511-25F400F6-7FF9-4395-86CE-CC31E8B6265A

P2888

Q24801511-954692F8-61F1-4554-B28D-618A9BFC1E06

P304

Q24801511-AC9B9903-7DD9-4F9C-9D5D-EB66C9581D05

P31

Q24801511-507C4698-C6CB-47EF-A8E5-43EC260250FE

Q24801511-E9911D41-30B7-451C-955F-DEC3F618662D

P3181

Q24801511-20C9D770-CC6A-4845-8D66-59A66DD52213

P356

Q24801511-85ACE021-45AD-4282-8467-F336051FF4E4

P407

Q24801511-46F4B62A-1C31-4856-B61E-DF0430A66EEE

P433

Q24801511-C09B0F10-BE99-4187-BDB3-0944A538B5EC

P478

Q24801511-F8813BBE-678A-4952-A894-B04A06D7F66C

P577

Q24801511-4B54CFA1-152A-4C3D-8A4B-A4DC026BB83D

P5875

Q24801511-9EEC660C-281D-47BB-A4BC-E9873996C44A

P6179

Q24801511-A816B5ED-3BB1-46F7-85CB-D068BBFE53EB

P698

Q24801511-66B55DA6-025B-4DB2-8990-05ED5968B65A

P921

Q24801511-98D9E407-86A7-413A-A001-F28D2FD374B7

Q24801511-A1098558-2CBB-4402-87B5-9A8BF3E76076

Q24801511-c060a499-47d6-75bd-822c-0b99338643c2

P932

Q24801511-0386C32C-50D7-4C24-8188-A2402447D60B

P3181

P356

P1433

Molecular Cancer

P1476

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

@en

P2093

Guido Eibl

http://www.w3.org/2001/XMLSchema#string

Howard A Reber

http://www.w3.org/2001/XMLSchema#string

John P Duffy

http://www.w3.org/2001/XMLSchema#string

Oscar J Hines

http://www.w3.org/2001/XMLSchema#string

P2860

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

P2888

P304

12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2387688

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1476-4598-2-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10883143

http://www.w3.org/2001/XMLSchema#string

P6179

1020474061

http://www.w3.org/2001/XMLSchema#string

P698

12605718

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

pancreatic neoplasm

P932

150383

http://www.w3.org/2001/XMLSchema#string